Biotech of the week: Enterome, the Leading French Microbiome Start-up
This week we've left the sunny Portuguese coast behind us and arrived in the 'City…
09/10/2015 - 2 minutes
Microbiome: An Emerging Field with Growing Investments
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Show More
Editor's Picks for Microbiome
- UK Startup Surfs Investment Wave in Microbiome with €18M Series A
- Microbiome Medicines Could Power Up CAR-T Cell Therapies
- Investing in the Microbiome in the Age of Covid-19 and Beyond
- The Missing Piece in the Microbiome Field
- No Guts, No Glory: How Microbiome Research is Changing Medicine
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportLatest Microbiome Articles
Breast-milk therapy for Microbiome disease makes BioGaia smile
BioGaia is a leading microbiome biotech from Stockholm (Sweden) who use the beneficial bacterium Lactobacillus…
11/09/2015 - 2 minutes
Gut bacteria growth time can cause disease?
A method of profiling bacterial growth time in the gut's microbiome has been shown to…
04/09/2015 - 3 minutes
The 5 things outside Europe you need to know this week (Samsung $1Bn Biotech IPO, Microbiome blindness, Google Biotech)
Hi there! Here are the 5 most important Biotech things that happened outside Europe in…
27/08/2015 - 2 minutes
Meet Eligo, the Startup which Raised €2M to Redefine Antibiotics using CRISPR
Antibiotic resistance is a public health problem worldwide. According to WHO, by 2050, over 10 million…
09/07/2015 - 6 minutes
The Institut Pasteur and IntegraGen, allies to Strengthen High-Throughput Sequencing in Microbiology
IntegraGen and the Institut Pasteur signed an agreement for high-throughput sequencing in the field of…
25/03/2015 - 2 minutes
The World’s First €100M Microbiome-focused Venture Fund opened in France
Microbiomics is one of the next big trends in the Biotech industry. Using bacteria present in…
19/03/2015 - 3 minutes
Promising Collaboration Between Evotec and Second Genome
Evotec AG and Second Genome decided to collaborate in small molecule-based discovery and development activities…
14/03/2015 - 2 minutes
Will 4D Pharma be UK’s next Microbiome leader?
4D Pharma, a biopharmaceutical company focusing on significant new therapeutic areas, plan to raise €46M…
02/02/2015 - 3 minutes
Will Nestlé lead the promising microbiome industry?
Nestlé is one of the food giants in the World. Last Tuesday, it made a huge…
09/01/2015 - 2 minutes
